
Biotech Forecast
Administrators-
Content count
116 -
Joined
-
Last visited
Community Reputation
0 NeutralAbout Biotech Forecast
-
Rank
Advanced Member
-
Do you want to share your biotech stock trading knowledge and gain access to advanced tools? If yes, contact us to become an advanced member. Benefits and characteristics of advanced members are: Advanced members are those member who have taken our course and show good knowledge of biotech investing. You are given more tools to track events and customize content. Can create a blog and write engaging content for whole the community to enjoy. Enter events into our Biotech Event Tracker and then follow these events in your activity stream. Create, edit and update these events as they happen.
-
Biotech Forecast started following Biotech Forecast Dark Blue
-
-
What will happen to ICPT stock prior to May 29th?
Biotech Forecast replied to Mark Wilson's topic in General Biotech Investing Discussion
The PDUFA date of May 29th, 2016 has been added to the event tracker. As a reminder, the company will have to do a confirmatory phase 4 trial per the requirements of the FDA accelerated approval. -
Intercept (ICPT) PDUFA of Ocaliva for primary biliary cholangitis
Biotech Forecast posted an event in Biotech Events
-
- intercept pharmaceuticals
- icpt
- (and 3 more)
-
Capricor (CAPR) Phase 1/2 Results of CAP-1002 for Duchenne muscular dystrophy associated cardiomyopathy
Biotech Forecast posted an event in Biotech Events
-
- capricor therapeutics
- capr
-
(and 1 more)
Tagged with:
-
Galmed (GLMD) Phase 2b Topline Results of Aramchol in NASH
Biotech Forecast posted an event in Biotech Events
-
Galmed (GLMD) Phase 2b Interim Results of Aramchol in NASH
Biotech Forecast posted an event in Biotech Events
-
Alcobra (ADHD) Phase 3 Results of Metadoxine for ADHD in Adults
Biotech Forecast posted an event in Biotech Events
-
Lipocine (LPCN) PDUFA of LPCN 1021 for Testosterone Replacement Therapy
Biotech Forecast posted an event in Biotech Events
-
ADMA Biologics (ADMA) PDUFA of RI-002 for Infection Prevention in Primary Immunodeficiency Disease
Biotech Forecast posted an event in Biotech Events
-
- adma biologics
- adma
-
(and 1 more)
Tagged with:
-
Ocular Therapeutix (OCUL) PDUFA of DEXTENZA for post-surgical ocular pain
Biotech Forecast posted an event in Biotech Events
-
Opexa Therapeutics (OPXA) Phase 2b Results of Tcelna for Secondary Progressive MS
Biotech Forecast posted an event in Biotech Events
-
- opexa therapeutics
- opxa
-
(and 2 more)
Tagged with: